Macrophage activation syndrome (MAS) in juvenile systemic lupus erythematosus (JSLE): an underrecognized complication?

by Parodi, A, Davì, S, Pringe, AB, Magni-Manzoni, S, Miettunen, P, Bader-Meunier, B, Espada, G, Ozen, S, Wright, D, Magalhaes, C, Woo, P, Kubchandani, R, Grom, A, Michels, H, Wouters, C, Gutierrez, CE Toro, Sterba, G, Hayward, K, Guseinova, D, Fischer, A, Cortis, E, Vivarelli, M, Pistorio, A, Ruperto, N, Sala, I, Martini, A, Ravelli, A
Published 2008

PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate

by Ruperto, N, Pistorio, A, Knupp Feitosa de Oliveira, S, Cuttica, R, Ravelli, A, Fischbach, M, Magnusson, B, Avcin, T, Brochard, K, Corona, F, Couillault, G, Dressler, F, Gerloni, V, Sterba, G, Zulian, F, Apaz, MT, Cespedes-Cruz, A, Cimaz, R, Bracaglia, C, Joos, R, Quartier, P, Russo, R, Tardieu, M, Wulffraat, N, Angioloni, S, Martini, A
Published 2013